Join the Novolog group to help and get support from people like you.
Novolog News
FDA Medwatch Alert: Novo Nordisk Issues Voluntary Nationwide Recall of Levemir, Tresiba, Fiasp, Novolog and Xultophy Product Samples Due to Improper Storage Temperature Conditions
May 10, 2021 – Novo Nordisk is voluntarily recalling 1,468 product samples listed in the table below of Levemir®, Tresiba®, Fiasp®, Novolog® and Xultophy®, to the consumer level. These products are b...
FDA Medwatch Alert: Caution When Using Pen Needles to Inject Medicines: FDA Safety Communication
Audience: Patients and caregivers who use or are considering using pen injectors with pen needles to inject prescription medicines. Health care providers who treat patients, or who train...
Novo Nordisk Receives FDA Approval for Fiasp (insulin aspart injection), a New Fast-Acting Mealtime Insulin
PLAINSBORO, N.J., Sept. 29, 2017 /PRNewswire/ – Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved Fiasp (insulin aspart injection) 100 Units/mL, a fast-acting...
FDA Medwatch Alert: NovoLog insulin aspart [rDNA origin] injection)
[Posted 09/14/2005] Novo Nordisk Incorporated and FDA notified pharmacists of an initiative implemented to help prevent dispensing errors. To facilitate the dispensing of the correct product, color...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Diabetes, Type 2, Diabetes, Type 1